Industry reports
Editor highlights

Publication dates

» Purchase Premium Reports

1-10 of about 100 reports for Recombinant Protein
China Genetic Engineering Drug Industry Report, 2011-2012

China Genetic Engineering Drug Industry Report, 2011-2012

  • $ 1 900
  • Industry report
  • July 2012
  • by Research In China

... Human insulin, 2008-2011research schedule of amoytop biotech's long-acting recombinant protein drugs, as of 2011 ...

Life Science Tools and Reagents: Global Markets

Life Science Tools and Reagents: Global Markets

  • $ 6 650
  • Industry report
  • January 2014
  • by BCC Research

... Proteomics-related products and services (protein expression, purification and identification market); recombinant proteins market and in vitro assay development; antibodies as a research tool; cell biology ...

Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)

Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)

  • $ 4 650
  • Industry report
  • December 2012
  • by MarketsandMarkets

... Market (2012 - 2017) transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene ...

Product Strategies for Non-Oral Hematology Drugs

Product Strategies for Non-Oral Hematology Drugs

  • $ 2 850
  • Industry report
  • June 2012
  • by Greystone Research Associates

... And recombinant proteins designed to treat chronic conditions that are life threatening and often debilitating illnesses. As the availability of drugs based on new apis or molecular entities has grown, the product ...

Global Biopharmaceutical Market Report & Forecast (2012-2017)

Global Biopharmaceutical Market Report & Forecast (2012-2017)

  • $ 1 200
  • Industry report
  • September 2012
  • by International Market Analysis Research and Consult

... Forecast (2012-2017)5.3 Market segmentation by indication5.4 Market segmentation by class5.4.1 recombinant proteins5.4.1.1 Current performance (2005-2011)5.4.1.2 Market forecast (2012 ...

Vybion, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vybion, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

... Summary, 2007 to ytd 2013 8als biopharma enters into licensing agreement with vybion 9vybion enters into licensing agreement with cornell university 10meridian bioscience acquires recombinant ...

Drug Self-Administration Markets to 2016: Devices, Drugs, Markets, Strategies and Forecasts

Drug Self-Administration Markets to 2016: Devices, Drugs, Markets, Strategies and Forecasts

  • $ 4 850
  • Industry report
  • January 2012
  • by Greystone Research Associates

... Drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant ...

Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts

Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts

  • $ 4 850
  • Industry report
  • March 2013
  • by Greystone Research Associates

... Device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved ...

Drug Self-Administration Markets to 2018 - Drug Products, Indications, Markets and Forecasts

Drug Self-Administration Markets to 2018 - Drug Products, Indications, Markets and Forecasts

  • $ 4 850
  • Industry report
  • March 2013
  • by Greystone Research Associates

... Drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant ...

Drug Injection Devices to 2018

Drug Injection Devices to 2018

  • $ 4 850
  • Industry report
  • September 2013
  • by Greystone Research Associates

... Device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.